Invention Grant
US08715664B2 Use of human TNFα antibodies for treatment of erosive polyarthritis
有权
使用人类TNFα抗体治疗侵蚀性多发性关节炎
- Patent Title: Use of human TNFα antibodies for treatment of erosive polyarthritis
- Patent Title (中): 使用人类TNFα抗体治疗侵蚀性多发性关节炎
-
Application No.: US11435844Application Date: 2006-05-16
-
Publication No.: US08715664B2Publication Date: 2014-05-06
- Inventor: Rebecca S. Hoffman , Mark Weinberg
- Applicant: Rebecca S. Hoffman , Mark Weinberg
- Applicant Address: BM Hamilton
- Assignee: AbbVie Biotechnology Ltd.
- Current Assignee: AbbVie Biotechnology Ltd.
- Current Assignee Address: BM Hamilton
- Agency: Foley Hoag LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24
Abstract:
The invention describes methods of treating erosive polyarthritis comprising administering a TNFα antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNFα antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
Public/Granted literature
- US20070071747A1 Use of TNFalpha inhibitor for treatment of erosive polyarthritis Public/Granted day:2007-03-29
Information query
